Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Cannabis and tobacco smoke are not equally carcinogenic.

Melamede R.

Harm Reduct J. 2005 Oct 18;2:21.

2.
3.

Drug interactions with tobacco smoking. An update.

Zevin S, Benowitz NL.

Clin Pharmacokinet. 1999 Jun;36(6):425-38. Review.

PMID:
10427467
4.

Tobacco industry use of corporate social responsibility tactics as a sword and a shield on secondhand smoke issues.

Friedman LC.

J Law Med Ethics. 2009 Winter;37(4):819-27. doi: 10.1111/j.1748-720X.2009.00453.x.

PMID:
20122118
5.

Tobacco cessation interventions for young people.

Grimshaw GM, Stanton A.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003289. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD003289.

PMID:
17054164
6.

Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications.

Minnes S, Lang A, Singer L.

Addict Sci Clin Pract. 2011 Jul;6(1):57-70. Review.

7.

The effects of tobacco smoke and nicotine on cognition and the brain.

Swan GE, Lessov-Schlaggar CN.

Neuropsychol Rev. 2007 Sep;17(3):259-73. Epub 2007 Aug 10. Review.

PMID:
17690985
8.

Smokeless tobacco and cardiovascular disease.

Asplund K.

Prog Cardiovasc Dis. 2003 Mar-Apr;45(5):383-94. Review.

PMID:
12704595
9.

Acute effects of electronic and tobacco cigarette smoking on complete blood count.

Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y.

Food Chem Toxicol. 2012 Oct;50(10):3600-3. doi: 10.1016/j.fct.2012.07.025. Epub 2012 Jul 31.

PMID:
22858449
10.

A small-cell lung cancer genome with complex signatures of tobacco exposure.

Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, OrdoƱez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ.

Nature. 2010 Jan 14;463(7278):184-90. doi: 10.1038/nature08629. Epub 2009 Dec 16.

11.

Smokeless tobacco and cancer.

Boffetta P, Hecht S, Gray N, Gupta P, Straif K.

Lancet Oncol. 2008 Jul;9(7):667-75. doi: 10.1016/S1470-2045(08)70173-6. Review.

PMID:
18598931
12.

Effects of abstinence from tobacco: valid symptoms and time course.

Hughes JR.

Nicotine Tob Res. 2007 Mar;9(3):315-27. Review.

PMID:
17365764
13.

Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000.

Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy W, Boer R, Gorlova O, Gazelle GS, Kimmel M, McMahon PM, de Koning HJ, Feuer EJ.

J Natl Cancer Inst. 2012 Apr 4;104(7):541-8. doi: 10.1093/jnci/djs136. Epub 2012 Mar 14.

14.

Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.

Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S; INTERHEART Study Investigators.

Lancet. 2006 Aug 19;368(9536):647-58.

PMID:
16920470
15.

Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis.

Underwood JM, Townsend JS, Tai E, White A, Davis SP, Fairley TL.

J Cancer Surviv. 2012 Sep;6(3):333-44. doi: 10.1007/s11764-012-0230-1. Epub 2012 Jun 16.

16.

Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.

Lovato C, Linn G, Stead LF, Best A.

Cochrane Database Syst Rev. 2003;(4):CD003439. Review. Update in: Cochrane Database Syst Rev. 2011;(10):CD003439.

PMID:
14583977
17.

Smokeless tobacco and oral cancer: a review of the risks and determinants.

Rodu B, Jansson C.

Crit Rev Oral Biol Med. 2004 Sep 1;15(5):252-63. Review.

18.

Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys.

Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, Peto R, Zatonski W, Hsia J, Morton J, Palipudi KM, Asma S; GATS Collaborative Group.

Lancet. 2012 Aug 18;380(9842):668-79. doi: 10.1016/S0140-6736(12)61085-X. Review. Erratum in: Lancet. 2013 Jul 13;382(9887):128. Lancet. 2012 Dec 1;380(9857):1908.

PMID:
22901888
19.

Non-cigarette tobacco products: what have we learnt and where are we headed?

O'Connor RJ.

Tob Control. 2012 Mar;21(2):181-90. doi: 10.1136/tobaccocontrol-2011-050281. Review.

20.

Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.

Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N.

Cell. 2011 Oct 14;147(2):293-305. doi: 10.1016/j.cell.2011.08.035.

Items per page

Supplemental Content

Write to the Help Desk